Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
Clinical trial NCT05592418 · COMPLETED
Trial details
- NCT number
- NCT05592418
- Sponsor
- AIM ImmunoTech Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-30
- Primary completion
- 2023-11-17
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.